Put Options

15 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

BUY
$76.85 - $89.45 $7.81 Million - $9.09 Million
101,600 Added 80.19%
228,300 $17.7 Million
Q4 2021

Feb 15, 2022

BUY
$74.57 - $87.19 $2.66 Million - $3.11 Million
35,700 Added 39.23%
126,700 $10.9 Million
Q3 2021

Nov 16, 2021

BUY
$73.77 - $83.61 $3.9 Million - $4.42 Million
52,900 Added 138.85%
91,000 $7.32 Million
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $1.48 Million - $1.62 Million
-18,400 Reduced 32.57%
38,100 $3.07 Million
Q1 2021

May 18, 2021

BUY
$76.38 - $86.03 $2.34 Million - $2.63 Million
30,600 Added 118.15%
56,500 $4.77 Million
Q4 2020

Feb 17, 2021

SELL
$75.39 - $82.36 $9.2 Million - $10 Million
-122,000 Reduced 82.49%
25,900 $2.08 Million
Q3 2020

Nov 17, 2020

BUY
$78.33 - $90.73 $8.29 Million - $9.6 Million
105,800 Added 251.31%
147,900 $11.9 Million
Q2 2020

Aug 17, 2020

BUY
$78.66 - $94.14 $3.09 Million - $3.7 Million
39,300 Added 1403.57%
42,100 $3.63 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $1.18 Million - $1.54 Million
-16,500 Reduced 85.49%
2,800 $227,000
Q4 2019

Feb 14, 2020

SELL
$76.7 - $88.45 $567,580 - $654,530
-7,400 Reduced 27.72%
19,300 $1.61 Million
Q2 2019

Aug 15, 2019

BUY
$73.44 - $82.41 $1.75 Million - $1.96 Million
23,800 Added 820.69%
26,700 $2.19 Million
Q1 2019

May 16, 2019

SELL
$64.48 - $81.31 $11.1 Million - $14 Million
-172,400 Reduced 98.35%
2,900 $236,000
Q2 2018

Aug 15, 2018

BUY
$63.43 - $75.41 $10.3 Million - $12.2 Million
161,800 Added 1198.52%
175,300 $12.9 Million
Q1 2018

May 15, 2018

BUY
$62.56 - $72.26 $469,200 - $541,950
7,500 Added 125.0%
13,500 $878,000
Q4 2017

Feb 15, 2018

BUY
$61.45 - $66.05 $368,700 - $396,300
6,000
6,000 $388,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $17.5B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.